Grant: Discovery Grants Program - Individual
University of Victoria
$22,000.00
In vitro biomimetic microfluidic models for toxicology studies
EF 2020-21
Résumé
Lipid bilayers are complex and ubiquitous entities that regulate fundamental processes within cellular environments. In particular, the complexity of lipid bilayers and how they mediate the transport of drugs and molecules into cells is an essential unsolved problem in biology, which has damaging ramifications for drug discovery.
The miniaturisation of chemical and biological systems is a recent, but exciting trend in the natural sciences, providing a host of advantages such as enhanced analytical throughput, reduced sample sizes and heightened control over experimental parameters. Microfluidic platforms in particular, where the technology is designed to manipulate fluids on the microscale, have allowed the development of artificial cell-type systems using volumes and scales that are comparable to real cells.
The aim of my research program is to develop miniaturised bottom-up methods for the formation of biomimetic lipid bilayers that allow the analysis of transport across them and enable the study of their properties. These platforms will allow complete control over each component of a bilayer system, from lipid composition to bilayer size and architecture.
This research program will harness the power of microfluidic devices to answer fundamental questions regarding the mechanism of bilayer transport. To ensure that the application of microfluidic technologies to these problems has a lasting effect on the way that the pharmaceutical industry develops new drugs, from the start, this research program will be informed by the needs of industry through collaborations with domain specialists so that all developments have the potential to be used in pharmaceutical environments. As such, there are a series of modules that need to be developed, such as on-chip biosensors, biomimetic lipid formulations, and microfluidic platforms using materials that allow mass-production.
The multidisciplinary nature of this research program has numerous advantages for the researchers involved. They will be trained in a variety of widely applicable techniques (such as microfluidic device design and fabrication), will become adept at problem solving in a variety of scientific research fields (such as analytical chemistry, biology and engineering) and will benefit from collaborations both with academic experts and industry contacts.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2017-04844
Name nom
Elvira, Katherine
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2017
Award amount
22000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:4-5
Partie
2
Nb partie
5
Application title
In vitro biomimetic microfluidic models for toxicology studies
Keyword
NSERC
Application summary
Lipid bilayers are complex and ubiquitous entities that regulate fundamental processes within cellular environments. In particular, the complexity of lipid bilayers and how they mediate the transport of drugs and molecules into cells is an essential unsolved problem in biology, which has damaging ramifications for drug discovery.
The miniaturisation of chemical and biological systems is a recent, but exciting trend in the natural sciences, providing a host of advantages such as enhanced analytical throughput, reduced sample sizes and heightened control over experimental parameters. Microfluidic platforms in particular, where the technology is designed to manipulate fluids on the microscale, have allowed the development of artificial cell-type systems using volumes and scales that are comparable to real cells.
The aim of my research program is to develop miniaturised bottom-up methods for the formation of biomimetic lipid bilayers that allow the analysis of transport across them and enable the study of their properties. These platforms will allow complete control over each component of a bilayer system, from lipid composition to bilayer size and architecture.
This research program will harness the power of microfluidic devices to answer fundamental questions regarding the mechanism of bilayer transport. To ensure that the application of microfluidic technologies to these problems has a lasting effect on the way that the pharmaceutical industry develops new drugs, from the start, this research program will be informed by the needs of industry through collaborations with domain specialists so that all developments have the potential to be used in pharmaceutical environments. As such, there are a series of modules that need to be developed, such as on-chip biosensors, biomimetic lipid formulations, and microfluidic platforms using materials that allow mass-production.
The multidisciplinary nature of this research program has numerous advantages for the researchers involved. They will be trained in a variety of widely applicable techniques (such as microfluidic device design and fabrication), will become adept at problem solving in a variety of scientific research fields (such as analytical chemistry, biology and engineering) and will benefit from collaborations both with academic experts and industry contacts.